Results 251 to 260 of about 771,983 (316)

Optogenetic‐Controlled iPSC‐Based Vaccines for Prophylactic and Therapeutic Tumor Suppression in Mice

Advanced Science, EarlyView.
This study develops an a red/far‐red light‐controlled iPSC‐based vaccines (RIVA) based on the chimeric photosensory protein FnBphP and its interaction partner LDB3 for cancer immunotherapy. The RIVA preserves the multiple intrinsic tumor antigens of iPSCs and enables optogenetic control of the expression of the immune adjuvant type I interferon β under
Longliang Qiao, Lingxue Niu, Zhihao Wang, Di Dai, Shasha Tang, Xiaoding Ma, Zhenqiang Deng, Guiling Yu, Yang Zhou, Tao Yan, Xingwan Liu, Deqiang Kong, Linfeng Hu, Xiang Li, Junwei Zhao, Fengfeng Cai, Meiyan Wang, Haifeng Ye   +17 more
wiley   +1 more source

Monoclonal antibody neutralizes <i>Staphylococcus aureus</i> serine protease-like protein B (SplB)-induced pathology. [PDF]

Infect Immun
Iqbal J, von Fournier J, Wittmann N, Darisipudi MN, Mrochen DM, Smiljanov B, Surmann K, Wockenfuß G, Steil L, Kohler TP, Glinka FL, Peringathara S, Saade C, Fernandes LM, Bornscheuer U, Reichel CA, Bröker BM, Raafat D, Holtfreter S.   +18 more
europepmc   +1 more source

Advancing Non-Invasive Colorectal Cancer Screening: Exploring the Potential of Monoclonal Antibody L2A5. [PDF]

Int J Mol Sci
Caldevilla R, Eiras M, Santos DAR, Almeida J, Oliveira B, Loureiro S, Soares J, Gonzalez-Santos M, Ramos N, Videira PA, Santos LL, Dinis-Ribeiro M, Lima L.   +12 more
europepmc   +1 more source

Immunobridging for Pemivibart, a Monoclonal Antibody for Prevention of Covid-19. [PDF]

N Engl J Med
Schmidt P, Li Y, Popejoy M.
europepmc   +1 more source

Development of the TSR-based computational method to investigate spike and monoclonal antibody interactions. [PDF]

Front Chem
Milon TI, Sarkar T, Chen Y, Grider JM, Chen F, Ji JY, Jois SD, Kousoulas KG, Raghavan V, Xu W.   +9 more
europepmc   +1 more source

Targeting glial fibrillary acidic protein in glaucoma: a monoclonal antibody approach to modulate glial reactivity and neuroinflammation for neuroprotection. [PDF]

J Neuroinflammation
Guan C, Zhang L, Fomo KN, Yang J, Pfeiffer N, Grus FH.   +5 more
europepmc   +1 more source

8C7: A Fully Human Anti-PTGFRN Monoclonal Antibody-Drug Conjugate Inhibiting Tumour Growth of Mesothelioma and Paediatric Medulloblastoma Cell Lines. [PDF]

J Cell Mol Med
Marquez J, Dong J, Yue B, Hayashi J, Dong C, Oshimura M, Serrero G.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Monoclonal Antibodies

New England Journal of Medicine, 1981
Serologic reagents have played an important role in the diagnosis, treatment, and epidemiology of infectious diseases. A new technology has been developed for generating homogeneous antibodies that can be produced in large amounts and are available indefinitely. This technique promises to increase the reliability and sensitivity of immunoassays and may
M D, Scharff, S, Roberts, P, Thammana
openaire   +4 more sources

Production of Monoclonal Antibodies [PDF]

Current Protocols in Immunology, 1992
AbstractThis unit describes the production of monoclonal antibodies beginning with immunization, cell fusion, and selection. Support protocols are provided for screening primary hybridoma supernatants for antibodies of desired specificity, establishment of stable hybridoma lines, cloning of these B cell lines by limiting dilution to obtain monoclonal ...
Wayne M, Yokoyama, Michelle, Christensen, Gary Dos, Santos, Diane, Miller, Jason, Ho, Tao, Wu, Michael, Dziegelewski, Francisca A, Neethling   +7 more
openaire   +6 more sources